We have previously shown in Atlantic salmon that the rate of fluid absorption by the posterior intestine (Jv) is elevated during the smolt stage in spring as a preadaptive development for osmoregulation in seawater. In the present study, we examined developmental differences in the responsiveness of Jv to cortisol and the corticosteroid antagonist, RU 486, through the parr-smolt transformation. Freshwater, juvenile salmon were administered slow-release implants of cortisol (50 micrograms/g body wt), RU 486 (1 mg/g body wt), or the implant without steroid (controls) at seven times from November 1992 through June 1993. Seven and 8 days after implantation, plasma cortisol concentrations and in vitro Jv were measured. In control salmon, both plasma cortisol and Jv peaked in April and were positively correlated over time. Cortisol implants stimulated Jv of salmon only during the parr and postsmolt stages, when Jv of controls was low. The exogenous cortisol was sufficient to stimulate Jv to a rate comparable to that measured for control salmon in the smolt stage. Conversely, RU 486 implants inhibited Jv only during the peak smolt period, when Jv of controls was elevated. Taken together, these results demonstrate that cortisol is a necessary and sufficient endocrine signal mediating this developmental change in intestinal function during parr-smolt transformation. This is the first report of plasma cortisol levels measured in fish treated with RU 486. Plasma cortisol was elevated by RU 486, suggesting that this corticosteroid antagonist blocked feedback inhibition on the pituitary-interrenal axis.

Download full-text PDF

Source
http://dx.doi.org/10.1006/gcen.1995.1024DOI Listing

Publication Analysis

Top Keywords

plasma cortisol
16
parr-smolt transformation
12
cortisol
10
fluid absorption
8
atlantic salmon
8
smolt stage
8
corticosteroid antagonist
8
measured control
8
control salmon
8
cortisol sufficient
8

Similar Publications

Co-existing autonomous cortisol secretion in primary aldosteronism.

Ann Endocrinol (Paris)

January 2025

Gazi University, Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkey. Electronic address:

Aim: Co-existing primary aldosteronism (PA) and autonomous cortisol secretion (ACS) has been recently recognized as a distinct entity. This study aimed to assess the incidence of ACS in patients with PA, and its impact on clinical and laboratory parameters.

Methods: Ninety-two patients diagnosed with PA were included.

View Article and Find Full Text PDF

Growth hormone (GH) secretion by the pituitary is regulated by stimulatory and inhibitory pathways such as growth hormone releasing hormone (GHRH) and somatostatin, respectively, being also modulated by different neurotransmitters acting at the hypothalamic/pituitary level. The pineal gland hormone melatonin regulates GH secretion in many mammals, including humans, although its role in modulating GH secretion has been debated. We describe the case of a young woman chronically taking melatonin for sleep disturbances, referring to her general practitioner for flushing that appeared just after starting melatonin intake.

View Article and Find Full Text PDF

A simple and efficient validated assay for quantifying 21-deoxycortisol (21-DOC), 17-hydroxyprogesterone (17-OHP), cortisol, and cortisone in human plasma has been developed using ultra-high performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS). Analysis of plasma samples were performed on Atlantis dC18 (3 m) column using a mobile phase of 20.0 mM ammonium acetate and acetonitrile (50:50, : ) that was delivered at isocratic flow rate 0.

View Article and Find Full Text PDF

Purpose: To evaluate the effect of osilodrostat and hypercortisolism control on blood pressure (BP) and glycemic control in patients with Cushing's disease.

Methods: Pooled analysis of two Phase III osilodrostat studies (LINC 3 and LINC 4), both comprising a 48-week core phase and an optional open-label extension. Changes from baseline in systolic and diastolic BP (SBP and DBP), fasting plasma glucose (FPG), and glycated hemoglobin (HbA) were evaluated during osilodrostat treatment in patients with/without hypertension or diabetes at baseline.

View Article and Find Full Text PDF

Background: Self-reported health problems following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are common and often include relatively non-specific complaints such as fatigue, exertional dyspnoea, concentration or memory disturbance and sleep problems. The long-term prognosis of such post-acute sequelae of COVID-19/post-COVID-19 syndrome (PCS) is unknown, and data finding and correlating organ dysfunction and pathology with self-reported symptoms in patients with non-recovery from PCS is scarce. We wanted to describe clinical characteristics and diagnostic findings among patients with PCS persisting for >1 year and assessed risk factors for PCS persistence versus improvement.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!